Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial

BACKGROUND: Trastuzumab has been approved for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic gastric carcinoma; however, relatively little is known about the role of HER2 in the natural history of this disease. PATIENTS AND METHODS: Patients enrolled in the INT-011...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gordon, M. A., Gundacker, H. M., Benedetti, J., Macdonald, J. S., Baranda, J. C., Levin, W. J., Blanke, C. D., Elatre, W., Weng, P., Zhou, J. Y., Lenz, H. J., Press, M. F.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2013
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3690906/
https://ncbi.nlm.nih.gov/pubmed/23524864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt106
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares